Catherine Duane, Siobhan Glavey, John Quinn, Philip Murphy
{"title":"静脉血栓栓塞的显著风险与靶向抗骨髓瘤免疫调节药物相关。评论:靶向抗癌药物与静脉血栓栓塞的风险。","authors":"Catherine Duane, Siobhan Glavey, John Quinn, Philip Murphy","doi":"10.3324/haematol.2025.287442","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":"2552-2553"},"PeriodicalIF":7.9000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12485318/pdf/","citationCount":"0","resultStr":"{\"title\":\"Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on \\\"Targeted anti-cancer agents and risk of venous thromboembolism\\\".\",\"authors\":\"Catherine Duane, Siobhan Glavey, John Quinn, Philip Murphy\",\"doi\":\"10.3324/haematol.2025.287442\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12964,\"journal\":{\"name\":\"Haematologica\",\"volume\":\" \",\"pages\":\"2552-2553\"},\"PeriodicalIF\":7.9000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12485318/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Haematologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3324/haematol.2025.287442\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haematologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3324/haematol.2025.287442","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on "Targeted anti-cancer agents and risk of venous thromboembolism".
期刊介绍:
Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research.
Scope:
The scope of the journal includes reporting novel research results that:
Have a significant impact on understanding normal hematology or the development of hematological diseases.
Are likely to bring important changes to the diagnosis or treatment of hematological diseases.